56 completed. 56 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 56 | Completed 56 |
Follow Dry Eye: new trials by email Literature Review of Dry Eye trials Research Report on Dry Eye
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens Wear Perfluorohexyloctane ophthalmic solution - Dry Eye | Phase 4 | Completed | Bausch & Lomb Incorporated | 104 | 2025-07-02 | 2025-12-18 |
| Topical Insulin for Ocular Surface Interface in Dry Eye Disease Artificial tear, insulin human - Dry Eye, Insulin Sensitivity | Phase 4 | Completed | Khyber Teaching Hospital | 128 | 2025-04-14 | 2026-08-14 |
| Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment Hormonal treatment - Braest Cancer, Dry Eye | Phase 4 | Completed | Sohag University | 40 | 2024-06-01 | 2025-04-11 |
| Treating Lid Wiper Epitheliopathy Preservative Free eye drop - Dry Eye, Visual Acuity | Phase 4 | Completed | Southern College of Optometry | 52 | 2024-05-27 | 2025-02-25 |
| A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy Miebo - Dry Eye | Phase 4 | Completed | Bausch & Lomb Incorporated | 97 | 2024-04-30 | 2026-07-06 |
| A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease Miebo - Dry Eye | Phase 4 | Completed | Bausch & Lomb Incorporated | 99 | 2024-02-28 | 2025-10-21 |
| Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study HPMC+GlicoPro eyedrops, Hydroxypropyl-methylcellulose - Dry Eye | Phase 4 | Completed | University of Milan | 44 | 2024-02-03 | 2024-12-10 |
| Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance Systane Complete Multi-Dose PF, Walgreen's Lubricant Balance - Dry Eye | Phase 4 | Completed | Scripps Poway Eyecare and Optometry | 70 | 2024-01-18 | 2025-04-08 |
| The COAT Trial: Cequa's Onset of Action Trial Cyclosporine ophthalmic solution - Dry Eye | Phase 4 | Completed | Research Insight LLC | 52 | 2023-10-12 | 2024-07-01 |
| Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Miebo - Dry Eye, Dry Eye, Evaporative | Phase 4 | Completed | Gordon Schanzlin New Vision | 49 | 2023-09-21 | 2024-04-09 |
| Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya Nasal Guide - Dry Eye, Keratoconjunctivitis Sicca | Phase 4 | Completed | Oyster Point Pharma, Inc. | 30 | 2023-06-14 | 2025-05-06 |
| Nasal Spray Study in Sjogren's Dry Eye Disease Varenicline Nasal Spray - Sjogren's Syndrome, Dry Eye | Phase 4 | Completed | University of Pennsylvania | 39 | 2023-05-01 | 2024-11-05 |
| Artificial Tears, Tear Lipids and Tear Film Dynamics Systane Complete PF, Refresh Relieva PF, Refresh Optive Mega-3 PF - Dry Eye | Phase 4 | Completed | University of California, Berkeley | 81 | 2023-01-30 | 2025-03-14 |
| Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye Insulin, Cyclosporins, Artificial tears - Dry Eye, Insulin | Phase 4 | Completed | Barbara Burgos Blasco | 116 | 2022-10-19 | 2026-03-05 |
| Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers Lifitegrast 5% Ophthalmic Solution, Lifitegrast Ophthalmic Solution Vehicle - Dry Eye | Phase 4 | Completed | State University of New York College of Optometry | 32 | 2022-09-22 | 2025-01-14 |
| Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%, Sodium hyaluronate 0.15%, Sodium hyaluronate 0.4% - Dry Eye | Phase 4 | Completed | Laboratorios Sophia S.A de C.V. | 182 | 2021-12-09 | 2026-02-20 |
| OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers OC-01 (varenicline 0.6mg/ml) Nasal Spray, Placebo (vehicle) nasal spray - Dry Eye | Phase 4 | Completed | Center for Ophthalmic and Vision Research, LLC | 75 | 2021-12-03 | 2022-11-03 |
| The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease artificial tear eyedrops, 0.05% cyclosporine eyedrops - Dry Eye | Phase 4 | Completed | Peking University Third Hospital | 60 | 2021-12-02 | 2025-02-13 |
| Digital Device Users Who Are Treated With Systane Hydration PF Systane Hydration PF - Dry Eye | Phase 4 | Completed | University of Alabama at Birmingham | 30 | 2021-08-18 | 2022-10-10 |
| The DEPOT Study (Dry Eye Prescription Options for Therapy) Dexamethasone - Dry Eye | Phase 4 | Completed | Research Insight LLC | 50 | 2021-08-10 | 2022-01-03 |
Showing 20 of 56. Sign in to see all of them.
Dry Eye Syndromes (56) · Insulin Resistance (2) · Sjogren's Syndrome (2) · Breast Neoplasms (1) · Cataract (1) · Diabetes Mellitus (1) · Keratitis (1) · Keratoconjunctivitis Sicca (1)
Eye Diseases (56) · Lacrimal Apparatus Diseases (56) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Skin and Connective Tissue Diseases (3) · Arthritis (2) · Arthritis, Rheumatoid (2) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Corneal Diseases (2) · Hyperinsulinism (2) · Immune System Diseases (2) · Joint Diseases (2) · Mouth Diseases (2)
Cyclosporins (7) · Ophthalmic Solutions (4) · lifitegrast (4) · Cyclosporine (3) · Hyaluronic Acid (3) · Lubricant Eye Drops (3) · perfluorohexyl-octan (3) · Calcium Dobesilate (2) · Insulin (2) · Standard of Care (2) · Carboxymethylcellulose Sodium (1) · Dexamethasone (1) · Hypromellose Derivatives (1) · Loteprednol Etabonate (1) · MCC protocol (1)
Innovative Medical (9) · Alcon Research (5) · Bausch & Lomb Incorporated (3) · Research Insight LLC (3) · University of Alabama at Birmingham (3) · Center for Ophthalmic and Vision Research, LLC (2) · Allergan (1) · Aston University (1) · Barbara Burgos Blasco (1) · Bp Consulting, Inc (1) · Durrie Vision (1) · Gordon Schanzlin New Vision (1) · Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA (1) · Khyber Teaching Hospital (1) · Laboratorios Sophia S.A de C.V. (1)
United States (33) · Austria (2) · Spain (2) · Canada (1) · China (1) · Egypt (1) · India (1) · Italy (1) · Mexico (1) · Pakistan (1) · Singapore (1) · South Korea (1) · Turkey (Türkiye) (1) · United Kingdom (1)
John Hovanesian, MD (3) · Andrew Hopkinson, PhD (1) · Barbara Burgos Blasco, MD, PhD (1) · Barry Schechter, MD (1) · Daniel S. Durrie, MD (1) · Danielle Iacono, OD (1) · David Hardten, MD (1) · Edoardo Villani, MD (1) · Eric Donnenfeld, MD (1) · Gail L Torkildsen, M.D. (1) · Hong Qi (1) · Jay Mashouf, OD (1) · Jay S Pepose, MD, PhD (1) · Jerry R Paugh (1)
PMID 22475641, PMID 27055211, PMID 27388660, PMID 28375789, PMID 28933582, PMID 30802601, PMID 31741283, PMID 38446281, PMID 39233999, PMID 39985746, PMID 40024993, PMID 40138387, PMID 40166690, PMID 40276144, PMID 41588216, PMID 42415246